Director, Business Development
Durham, North Carolina, Us
• Joined Chiltern, a global contract research organization (CRO), shortly before its acquisition by LabCorp for over $1 billion, a major event that expanded the company’s capabilities and global reach.• Led business development initiatives, focusing on identifying and cultivating opportunities within the pharmaceutical, biotechnology, and medical device industries.• Developed strategic engagement models and initiated discussions across key therapeutic areas, including oncology, biopharma, and medical devices, positioning Chiltern for future partnerships and growth in a competitive market.• Worked closely with cross-functional teams to align service offerings, such as Clinical Development and Data & Analysis, with client needs and industry trends, laying the groundwork for potential new business.• Positioned Chiltern for success during the transition period post-acquisition, leveraging the company’s enhanced capabilities to generate interest from potential clients and partners.• Focused on building a robust pipeline of business opportunities, setting the stage for future partnerships and client engagements that would drive long-term growth.